Diagnosing and Treating Infection in Ulcerative Colitis Patients with Worsening Symptoms
Initial Diagnostic Approach
- The American Gastroenterological Association recommends that patients with ulcerative colitis experiencing worsening symptoms should be evaluated for infection through stool testing for common pathogens, inflammatory markers assessment, and endoscopic evaluation when indicated 1, 2, 3
- Fecal calprotectin >150 mg/g, elevated fecal lactoferrin, or elevated CRP should be used to rule in active inflammation in patients with moderate to severe symptoms suggestive of UC flare 1, 4
- These biomarkers help differentiate between inflammatory flare and infection, though they cannot distinguish between them with complete certainty 2
- Full blood count may reveal thrombocytosis, anemia, or leucocytosis which could suggest infectious complications 2
Diagnostic Algorithm Based on Symptom Severity
- For patients with moderate to severe symptoms, the European Crohn’s and Colitis Organisation suggests testing for fecal calprotectin, fecal lactoferrin, and CRP, and obtaining stool cultures for infectious pathogens, especially C. difficile 1, 2, 4, 5
- If biomarkers are elevated (fecal calprotectin >150 mg/g), this reliably suggests moderate to severe endoscopic inflammation 5, 6
- Even with elevated biomarkers, infectious causes must still be excluded 2, 3
Identifying Specific Infections
- The American Gastroenterological Association recommends testing for C. difficile toxin in all UC patients with worsening symptoms, especially those recently treated with antibiotics, immunosuppressants, or corticosteroids 2
- Cytomegalovirus testing should be performed in treatment-refractory or severe relapse 2
Treatment Approach
- The American Gastroenterological Association suggests that immunosuppressive medications should be discontinued or adjusted as appropriate during active infection 3